SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 103 filers reported holding SYROS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 2.35 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $93,000 | -83.9% | 96,658 | -80.2% | 0.00% | – |
Q1 2022 | $579,000 | -66.2% | 487,083 | -7.2% | 0.00% | – |
Q4 2021 | $1,711,000 | -27.0% | 524,880 | +0.0% | 0.00% | – |
Q3 2021 | $2,345,000 | -22.4% | 524,679 | -5.4% | 0.00% | -100.0% |
Q2 2021 | $3,022,000 | -22.3% | 554,422 | +6.6% | 0.00% | 0.0% |
Q1 2021 | $3,890,000 | -20.6% | 519,905 | +15.1% | 0.00% | 0.0% |
Q4 2020 | $4,902,000 | +20.1% | 451,788 | -2.2% | 0.00% | 0.0% |
Q3 2020 | $4,082,000 | -22.2% | 461,835 | -6.1% | 0.00% | 0.0% |
Q2 2020 | $5,245,000 | +117.2% | 491,975 | +20.8% | 0.00% | 0.0% |
Q1 2020 | $2,415,000 | -12.9% | 407,341 | +1.5% | 0.00% | 0.0% |
Q4 2019 | $2,774,000 | -37.4% | 401,501 | -5.9% | 0.00% | 0.0% |
Q3 2019 | $4,431,000 | +44.2% | 426,851 | +28.7% | 0.00% | 0.0% |
Q2 2019 | $3,072,000 | +9.7% | 331,646 | +8.2% | 0.00% | 0.0% |
Q1 2019 | $2,801,000 | +64.3% | 306,454 | +0.1% | 0.00% | – |
Q4 2018 | $1,705,000 | -52.9% | 306,167 | +0.7% | 0.00% | -100.0% |
Q3 2018 | $3,620,000 | +28.6% | 303,988 | +10.3% | 0.00% | 0.0% |
Q2 2018 | $2,814,000 | +19.7% | 275,638 | +52.2% | 0.00% | 0.0% |
Q1 2018 | $2,351,000 | +80.2% | 181,090 | +35.0% | 0.00% | – |
Q4 2017 | $1,305,000 | -34.9% | 134,163 | -1.5% | 0.00% | -100.0% |
Q3 2017 | $2,006,000 | +114.5% | 136,264 | +134.7% | 0.00% | – |
Q2 2017 | $935,000 | +77.4% | 58,070 | +75.4% | 0.00% | – |
Q1 2017 | $527,000 | +60.2% | 33,098 | +22.4% | 0.00% | – |
Q4 2016 | $329,000 | – | 27,048 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|